全文获取类型
收费全文 | 3042篇 |
免费 | 187篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 49篇 |
妇产科学 | 29篇 |
基础医学 | 402篇 |
口腔科学 | 58篇 |
临床医学 | 255篇 |
内科学 | 763篇 |
皮肤病学 | 85篇 |
神经病学 | 378篇 |
特种医学 | 85篇 |
外科学 | 509篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 95篇 |
眼科学 | 33篇 |
药学 | 176篇 |
中国医学 | 10篇 |
肿瘤学 | 287篇 |
出版年
2023年 | 29篇 |
2022年 | 53篇 |
2021年 | 93篇 |
2020年 | 47篇 |
2019年 | 58篇 |
2018年 | 59篇 |
2017年 | 57篇 |
2016年 | 69篇 |
2015年 | 74篇 |
2014年 | 95篇 |
2013年 | 94篇 |
2012年 | 136篇 |
2011年 | 163篇 |
2010年 | 88篇 |
2009年 | 81篇 |
2008年 | 159篇 |
2007年 | 139篇 |
2006年 | 115篇 |
2005年 | 102篇 |
2004年 | 119篇 |
2003年 | 136篇 |
2002年 | 129篇 |
2001年 | 65篇 |
2000年 | 60篇 |
1999年 | 80篇 |
1998年 | 38篇 |
1997年 | 27篇 |
1996年 | 33篇 |
1992年 | 47篇 |
1991年 | 62篇 |
1990年 | 60篇 |
1989年 | 54篇 |
1988年 | 42篇 |
1987年 | 62篇 |
1986年 | 30篇 |
1985年 | 31篇 |
1984年 | 25篇 |
1983年 | 20篇 |
1980年 | 20篇 |
1979年 | 28篇 |
1978年 | 23篇 |
1977年 | 21篇 |
1975年 | 21篇 |
1974年 | 23篇 |
1972年 | 28篇 |
1971年 | 18篇 |
1970年 | 20篇 |
1969年 | 32篇 |
1967年 | 18篇 |
1966年 | 21篇 |
排序方式: 共有3243条查询结果,搜索用时 15 毫秒
101.
Hanako Nakajima Yoshitaka Hashimoto Ayumi Kaji Ryosuke Sakai Fuyuko Takahashi Yuta Yoshimura Ryo Bamba Takuro Okamura Noriyuki Kitagawa Saori Majima Takufumi Senmaru Hiroshi Okada Naoko Nakanishi Emi Ushigome Mai Asano Masahide Hamaguchi Masahiro Yamazaki Michiaki Fukui 《Journal of diabetes investigation.》2021,12(7):1202-1211
102.
Naoya Sakamoto Atsushi Kosaka Akifumi Imamura Fukumi Uchiyama-Nakamura Sentaro Iwabuchi Shigeko Nishimura Hiroshi Fujita 《Journal of infection and chemotherapy》2019,25(7):489-493
BackgroundEbola virus disease (EVD) was endemic to Africa in 2014–2016. Supportive therapies have been shown to improve the outcome of EVD, and additional supportive therapy including blood transfusion therapy and external circulation could be needed in the event of a future global outbreak. However, pre-transfusion testing policies and guidelines have not yet been established in Japan.MethodsWe conducted a cross-sectional study of blood transfusion therapy for EVD patients at three designated hospitals for serious communicable diseases in Tokyo. In each hospital, we surveyed blood transfusion therapy policy, blood transfusion protocol, presence of a specialist in the department of transfusion medicine, facility capacity for pre-transfusion compatibility testing, and types of personal protective equipment available.ResultsOne hospital had a cross-matched compatible blood transfusion policy, one had a cross-matched compatible blood transfusion policy only when the patient's ABO and RhD type is previously known, and the third had not created a policy. Two hospitals had a department of transfusion medicine. These two hospitals had a special testing unit for serious communicable diseases, while the other had a portable unit for testing. There were no major differences noted in available personal protective equipment.ConclusionPolicies and protocols differ among hospitals. The choice of blood transfusion policy and pre-transfusion testing is largely dependent on equipment and human resources. Further discussion is required to develop national guidelines for blood transfusion therapy in patients with serious communicable diseases, including countermeasures against complications and ethical issues related to the safety of patients and healthcare workers. 相似文献
103.
Satoshi Shimura Hideo Watari Masaru Komatsu Tomokazu Kuchibiro Saori Fukuda Hisaaki Nishio Machiko Kita Kaneyuki Kida Masanobu Oohama Hirofumi Toda Motoi Nishio Isao Nishi Keigo Kimura Kana Sawa Nozomi Fukuda Tomomi Kofuku Isako Nakai Makoto Niki Yasunao Wada 《Journal of infection and chemotherapy》2019,25(11):837-844
Obligate anaerobes exist as resident flora in various sites in humans, but they are also emphasized as endogenous causative microorganism of infections. We performed surveillance to understand the trend of drug susceptibility in obligate anaerobic bacteria in the Kinki area of Japan. In the experiment, we used 156 obligate anaerobe isolates collected from 13 institutions that participated in the Study of Bacterial Resistance Kinki Region of Japan. MALDI Biotyper was used to identify the collected strains, and among the 156 test strains, those that could be identified with an accuracy of Score Value 2.0 or more included 6 genera, 30 species, and 144 strains (Bacteroides spp. 77 strains, Parabacteroides sp. 2 strains, Prevotella spp. 29 strains, Fusobacterium spp. 14 strains, Porphyromonas spp. 2 strains, and Clostridioides difficile 20 strains), and they were assigned as subject strains for drug susceptibility testing. The drug susceptibility test was carried out by broth microdilution method using Kyokuto Opt Panel MP ANA (Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan) and judged according to CLSI criteria. As a result, Bacteroides and Parabacteroides species showed good sensitivities to tazobactam-piperacillin, imipenem, metronidazole and chloramphenicol, and low sensitivities to ampicillin, cefoperazone and vancomycin. Prevotella species showed good sensitivities to sulbactam-ampicillin, tazobactam-piperacillin, cefmetazole, imipenem, doripenem and metronidazole. Susceptibility rates to other drugs were slightly different depending on the bacterial species. Both Fusobacterium spp. and Porphyromonas spp. showed high sensitivities to many drugs. C. difficile was highly sensitive to vancomycin and metronidazole, having MIC90s of 0.5 μg/mL and ≤2 μg/mL, respectively. 相似文献
104.
Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma 总被引:14,自引:7,他引:14
Abe M Hiura K Wilde J Moriyama K Hashimoto T Ozaki S Wakatsuki S Kosaka M Kido S Inoue D Matsumoto T 《Blood》2002,100(6):2195-2202
Multiple myeloma (MM) cells cause devastating bone destruction by activating osteoclasts in the bone marrow milieu. However, the mechanism of enhanced bone resorption in patients with myeloma is poorly understood. In the present study, we investigated a role of C-C chemokines, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta, in MM cell-induced osteolysis. These chemokines were produced and secreted by a majority of MM cell lines as well as primary MM cells from patients. Secretion of MIP-1alpha and MIP-1beta correlated well with the ability of myeloma cells to enhance osteoclastic bone resorption both in vitro and in vivo as well as in MM patients. In osteoclastogenic cultures of rabbit bone cells, cocultures with myeloma cells as well as addition of myeloma cell-conditioned media enhanced both formation of osteoclastlike cells and resorption pits to an extent comparable to the effect of recombinant MIP-1alpha and MIP-1beta. Importantly, these effects were mostly reversed by neutralizing antibodies against MIP-1alpha and MIP-1beta, or their cognate receptor, CCR5, suggesting critical roles of these chemokines. We also demonstrated that stromal cells express CCR5 and that recombinant MIP-1alpha and MIP-1beta induce expression of receptor activator of nuclear factor-kappaB (RANK) ligand by stromal cells, thereby stimulating osteoclast differentiation of preosteoclastic cells. These results suggest that MIP-1alpha and MIP-1beta may be major osteoclast-activating factors produced by MM cells. 相似文献
105.
Tanaseanu C Moldoveanu E Kosaka T Tanaseanu S Neagu M Popescu LM 《European Journal of Internal Medicine》2004,15(5):291-297
BACKGROUND: Inflammatory reactions within coronary atherosclerotic plaques are increasingly thought to be crucial determinants of the clinical course in patients with coronary artery disease (CAD). Platelet-activating factor-acetylhydrolase (PAF-AH) is considered to reflect the ongoing inflammatory process in patients with CAD. Our objective was to determine the activity of PAF-AH in patients with stable angina and its correlations to lipoprotein levels and the inflammatory status of the patient. METHODS: Forty-five patients with documented CAD and stable angina and 20 controls were investigated for PAF-AH activity, lipoprotein levels, and peripheral neutrophil (PMN) activity. RESULTS: Patients were divided into two groups according to the values of PAF-AH activity (group 1: =250 IU/l and group 2: >250 IU/l). A correlation was observed between PAF-AH activity and LDL-C and HDL-C in controls and in all patients. The percentage of granulocytes generating intracellular O(2)(-) in unstimulated PMN was higher in group 2 patients than in group 1 patients and controls. The phagocytic activity of PMNs had an inverse correlation with PAF-AH in group 2. High intracellular O(2)(-) generation was coupled with low extracellular release of the anion and phagocytosis impairment in group 2. During the follow-up period, some of the patients in group 2 displayed a worsening of the clinical state and/or resting ECG changes. CONCLUSIONS: PAF-AH activity in patients with stable angina is correlated with hyperlipemia and a high PMN activation state, and it may be considered a potential predictor of vascular risk. 相似文献
106.
Dr. Akio Yamaguchi M.D. Yoshiyuki Kurosaka M.D. Tetsuya Ishida M.D. Genichi Nishimura M.D. Masahiro Kanno M.D. Takeo Kosaka M.D. Yutaka Yonemura M.D. Itsuo Miyazaki M.D. 《Diseases of the colon and rectum》1991,34(10):921-924
We examined serum NCC-ST 439 for its significance as a tumor marker of large bowel cancer in 121 patients with primary and 36 with recurrent large bowel cancer. Serum NCC-ST 439 was positive in 27.3 percent of the former and 66.7 percent of the latter. It was false-positive in only 5.6 percent of patients with benign diseases. Positive serum NCC-ST 439 correlated with lymph node and liver metastases. The combination assay for NCC-ST 439, CEA, and CA19-9 was positive in 49.6 percent of the patients with primary tumors and 88.9 percent of those with recurrent tumors; in other words, the diagnostic accuracy improved. The results demonstrated that the determination of serum NCC-ST 439 in large bowel cancer might be useful in cancer staging and that NCC-ST 439, if used in combination with CEA, is particularly useful in diagnosing recurrences because of its improved diagnostic accuracy. 相似文献
107.
Masafumi Kitakaze Koichi Node Kazuo Komamura Tetsuo Minamino Hiroaki Kosaka Tsunehiko Kuzuya Masatsugu Hori 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1999,13(5):407-414
ATP generates nitric oxide (NO) via activation of P2y receptors, and is degraded to adenosine. This study was undertaken to examine whether ATP causes coronary hyperemic flow via purinoceptors-, NO- and adenosine-dependent mechanisms, and attenuates the severity of contractile and metabolic dysfunction in the ischemic myocardium. In the non-ischemic canine hearts, the infusions of ATP into the coronary artery dose-dependently increased coronary blood flow. The levels of adenosine and end-product of NO in coronary venous blood over the arterial blood also increased. This hyperemic flow was partially attenuated by either 8-sulfophenyltheophylline (8SPT) or L-nitro arginine methyl ester (L-NAME), and completely blocked by the treatment with 8SPT, L-NAME and suramin (SRM). During myocardial ischemia, exogenous ATP increased coronary blood flow, and attenuated myocardial metabolic and contractile dysfunction, which was completely blunted by the treatment with 8SPT, L-NAME and SRM. We conclude that exogenous ATP increases coronary blood flow in the non-ischemic and ischemic myocardium mainly via either NO- or adenosine-dependent mechanisms. 相似文献
108.
Yamazato M Mano R Oshiro-Chinen S Tomiyama N Sakima A Ishida A Tana T Tozawa M Muratani H Iseki K Takishita S 《Internal medicine (Tokyo, Japan)》2002,41(10):864-866
A 33-year-old woman was referred from an outside dialysis clinic to our hospital because of severe abdominal pain during hemodialysis. She had been on chronic hemodialysis for the past 11 years due to chronic glomerulonephritis. Nafamostat mesilate was used as an anticoagulant for hemodialysis, because it was during her menstrual period with hypermenorrhea. On admission, she had no abdominal pain or gynecological abnormalities. On the second day, she had similar abdominal pain during hemodialysis with nafamostat mesilate in our dialysis unit. The abdominal pain disappeared within 60 minutes after discontinuing the hemodialysis. We re-started dialysis using heparin instead of nafamostat mesilate and she had no symptoms. The titer of total immunoglobulin E was high. The drug lymphocyte stimulation test was positive for nafamostat mesilate and antigen specific immunoglobulin E to nafamostat mesilate was highly positive in her blood. Although an allergic reaction to nafamostat mesilate is a rare complication, it should be one of the differential diagnoses of abdominal pain occurring during hemodialysis. 相似文献
109.
A Daibo Y Yoshida S Kitazawa Y Kosaka T Bando M Sudo 《Nihon Kyōbu Shikkan Gakkai zasshi》1992,30(8):1583-1588
We report a case of pneumonitis and hepatic injury caused by Sho-saiko-to. A 56-year-old man was admitted to our hospital because of hepatic disorder. The levels of serum transaminases returned to normal within two months without specific treatment and he was discharged. Four weeks later, he was readmitted because of severe pneumonitis and mild hepatic disorder. Under the suspicion of drug-induced pneumonitis, all medications were discontinued and high-dose glucocorticoid including "pulse therapy" was given. Consequently, pneumonitis and hepatic function markedly improved. Careful history taking revealed the ingestion of Sho-saiko-to before both admissions. Lymphocyte stimulation test against Sho-saiko-to was positive. Challenge test using Sho-saiko-to resulted in decrease of PaO2 and elevation of serum transaminases. Based on these findings, the diagnosis of pneumonitis and hepatic injury induced by Sho-saiko-to was established. 相似文献
110.
Nao Yoshida Ryoji Kobayashi Hiromasa Yabe Yoshiyuki Kosaka Hiroshi Yagasaki Ken-ichiro Watanabe Kazuko Kudo Akira Morimoto Shouichi Ohga Hideki Muramatsu Yoshiyuki Takahashi Koji Kato Ritsuro Suzuki Akira Ohara Seiji Kojima 《Haematologica》2014,99(12):1784-1791
The current treatment approach for severe aplastic anemia in children is based on studies performed in the 1980s, and updated evidence is required. We retrospectively compared the outcomes of children with acquired severe aplastic anemia who received immunosuppressive therapy within prospective trials conducted by the Japanese Childhood Aplastic Anemia Study Group or who underwent bone marrow transplantation from an HLA-matched family donor registered in the Japanese Society for Hematopoietic Cell Transplantation Registry. Between 1992 and 2009, 599 children (younger than 17 years) with severe aplastic anemia received a bone marrow transplant from an HLA-matched family donor (n=213) or immunosuppressive therapy (n=386) as first-line treatment. While the overall survival did not differ between patients treated with immunosuppressive therapy or bone marrow transplantation [88% (95% confidence interval: 86–90) versus 92% (90–94)], failure-free survival was significantly inferior in patients receiving immunosuppressive therapy than in those undergoing bone marrow transplantation [56% (54–59) versus 87% (85–90); P<0.0001]. There was no significant improvement in outcomes over the two time periods (1992–1999 versus 2000–2009). In multivariate analysis, age <10 years was identified as a favorable factor for overall survival (P=0.007), and choice of first-line immunosuppressive therapy was the only unfavorable factor for failure-free survival (P<0.0001). These support the current algorithm for treatment decisions, which recommends bone marrow transplantation when an HLA-matched family donor is available in pediatric severe aplastic anemia. 相似文献